Correlation Between Pmv Pharmaceuticals and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Lipella Pharmaceuticals.
Diversification Opportunities for Pmv Pharmaceuticals and Lipella Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pmv and Lipella is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Lipella Pharmaceuticals
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.85 times less risky than Lipella Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,368 in Lipella Pharmaceuticals Common on November 27, 2024 and sell it today you would lose (1,068) from holding Lipella Pharmaceuticals Common or give up 78.07% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pmv Pharmaceuticals vs. Lipella Pharmaceuticals Common
Performance |
Timeline |
Pmv Pharmaceuticals |
Lipella Pharmaceuticals |
Pmv Pharmaceuticals and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pmv Pharmaceuticals and Lipella Pharmaceuticals
The main advantage of trading using opposite Pmv Pharmaceuticals and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |